Plain-English translation of NCT07039604 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study following patients who have already received percutaneous pulmonary artery denervation (PADN)—a minimally invasive procedure that uses heat or cold to calm overactive nerves in the lung blood vessels. The study will track how well this treatment works for people with pulmonary arterial hypertension (a condition where blood pressure becomes dangerously high in the lungs). Researchers want to understand how the procedure performs outside of controlled clinical trials, in everyday medical practice.
Pulmonary arterial hypertension can be very difficult to treat, and current medications don't work well for everyone. This study exists to gather real-world evidence about whether this newer nerve-calming procedure can help patients breathe easier and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
Because this is a real-world study of patients who have already had the PADN procedure, your participation will mainly involve follow-up visits and health monitoring. Researchers will track your symptoms, blood pressure in your lungs, exercise tolerance, and overall quality of life over time. You'll be asked to share your medical records and continue with any other treatments your doctor recommends.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
Pulnovo Medical (Wuxi) Co., Ltd.
Enrollment target
~200 participants
Started
March 2025
Primary completion
December 2028
Last updated on clinicaltrials.gov in June 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.